Abstract
The recovery of 8 out of 12 patients with fulminating hepatitis after exchange transfusions, reported in the two papers by Trey et al. and Berger and his co-workers, published in this issue of the Journal, is an exciting observation that also presents many problems to the physician faced with the management of this rare but disturbing clinical event. So often, in the past, have new and drastic treatments been advocated on the basis of uncontrolled observations in a selected group of patients, and further experience, controlled or otherwise, resulted in eventual rejection of the procedure, that one must be . . .

This publication has 3 references indexed in Scilit: